Efficacy and safety by body weight decile in patients treated with tildrakizumab 100 mg for 28 weeks: Pooled data analysis of reSURFACE 1 and reSURFACE 2. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Nov. 6];7(2):s136. Available from: https://skin.dermsquared.com/skin/article/view/2007